Google image

Google X developing diagnosis pill

October 29, 2014
Medical Communications, Research and Development, Sales and Marketing AbbVie, Pfizer, calico, diagnosis pill, google, google x, vida, wearables

Google is developing a new pill designed to send microscopic particles into the bloodstream in an effort to identify cancers, …

nhs_parliament_2_8

Cancer Drugs Fund โ€˜papering over the cracks of a bigger issueโ€™

October 29, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, Kadcyla, NICE, breast cancer, reform

Breakthrough Breast Cancer has raised concerns to the government this week over the ever-increasing price of new oncology medicines. Over …

alison_doering

Quantum promotes senior head

October 29, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alison Doering, quantam pharmaceutical

Alison Doering has been promoted to head of group marketing and communications at medicines manufacturing firm Quantum Pharmaceutical.  Doering will …

PrimeVigilance Limited upgrades its validated databases for pharmacovigilance and medical information – ARISgโ„ข and agInquirerโ„ข.

October 28, 2014

PrimeVigilance Limited, a pharmaceutical service provider for Pharmacovigilance and Medical Information operations today announced the completion of a major upgrade …

Merck image

Merck revenue falls

October 28, 2014
Manufacturing and Production, Sales and Marketing Frazier, Merck, Q3, Victrelis, hep C, sovaldi

Merck has posted a set of disappointing financials for the latest quarter as it cuts cost across its business to …

peter_finan

Karus Therapeutics appoints two heads

October 28, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Peter Finan, Simon Roitt, karus

UK drug development firm Karus Therapeutics has grown its R&D team via two new appointments in Dr Simon Roitt, who …

Celgene image

Celgene expands immunotherapy pipeline with Sutro

October 27, 2014
Research and Development, Sales and Marketing Celgene, PD-1 and PD-L1, Q3, oncology, sutro

Celgene has extended its collaboration with Sutro Biopharma and added a buyout option for the firm as the two companies …

AZ image

AZ oncology drug a ‘Phoenix from the flamesโ€™

October 27, 2014
Sales and Marketing AstraZeneca, CHMP, EC, lynparza, olaparib, oncology

As the possibility of a deal with Pfizer fades, AstraZeneca is continuing its argument for independence as a key cancer …

Scenesse recommended for rare sun disease in Europe

October 27, 2014
Sales and Marketing CHMP, Clinuvel Pharmaceuticals, EMA, EU, scenesse

The European Medicines Agency is recommending that Scenesse (afamelanotide) be approved for the prevention of severe sun burn in adults …

France Focus: Power without responsibility?

October 27, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing France, Lantus, Sanofi, Servier, hollande, perindopril, report

Population: 65.8 million (2013) Government: Unitary semi-presidential constitutional republic Leader: Franรงois Hollande of the centre-left Socialist Party Gross Domestic Product: …

perez

Cubist Pharmaceuticals names chief executive

October 27, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cubist, perez

US biopharma firm Cubist Pharmaceuticals has named Robert Perez as its chief executive and who will begin the role from …

prof_paul_workman

Cancer drug discovery system โ€˜brokenโ€™

October 24, 2014
Research and Development, Sales and Marketing Cancer, cancer research, oncology, paul workman

The global system for discovering new cancer drugs is โ€˜brokenโ€™ and failing to turn scientific advances into enough innovative new …

Lilly image

Lacklustre sales hit Lilly again

October 24, 2014
Sales and Marketing Q3, cymbalta, humilin, lilly, sales, zyprexa

Lilly is enduring one of the bleakest financial years in its history as patent expiries continue to take chunks out …

prof_tony_young

Innovation director appointed to NHS England

October 24, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NHS England, tony young

NHS England has hired a new national clinical director for innovation in Professor Tony Young. Youngโ€™s role will be to …

UK government and partners pay ยฃ230m for disease research

October 23, 2014
Research and Development, Sales and Marketing Arthritis Research UK, British Heart Foundation, Cancer Research UK, London, MRC, Osborne, UK, Wellcome Trust, dementia, research

A new partnership led by the Medical Research Council and the UK government will invest over ยฃ230 million in a …

Viiv image

GSK mulls $27 billion ViiV sell-off

October 23, 2014
Medical Communications, Sales and Marketing AIDS, Advair, GSK, HIV, Pfizer, Q3, Shionogi, Tivicay, ViiV

After a difficult few years and another poor quarter, GlaxoSmithKline has announced that it is looking to float its fast-growing …

yana_ignatova

J&J appoints head of marketing in northern Europe

October 23, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Johnson and Johnson, yana Ignatova

Johnson & Johnson has appointed Yana Ignatova to the position of head of marketing for its northern Europe division. Reporting …

J&J image

J&J announces โ€˜major commitmentโ€™ to Ebola effort

October 22, 2014
Sales and Marketing Crucell, Ebola, J&J, JJ, Vaccine, bavarian, johnson, niaid

Johnson & Johnson will invest $200 million to accelerate and significantly expand the production of its Ebola vaccine programme. The …

Boehringer image

Boehringer seeks more indications for IPF drug

October 22, 2014
Research and Development, Sales and Marketing Boehringer, IPF, NSCLC, colectoral, crc, nintedanib, ofev

Boehringer Ingelheimโ€™s nintedanib has entered Phase III studies for the treatment of colorectal cancer (CRC), which could add to the …

Mark Baker image

NICE under increased pressure over conflicts of interest

October 22, 2014
Sales and Marketing GPs, NHS, NICE, UK, baker, conflict, mccoll, wollaston

A group of influential doctors is calling on the government to tighten up NICEโ€™s conflicts of interests policy. In a …

The Gateway to Local Adoption Series

Latest content